23andMe, the genetic testing giant once valued in the billions, is now navigating Chapter 11 bankruptcy and notifying millions of current and former customers that they may be eligible to file claims as part of the restructuring process. The company and 11 of its subsidiaries, including Lemonaid Health and LPRXOne, filed for bankruptcy protection on
Whoop has backed down, somewhat, from the controversial upgrade plans around its Whoop 5.0 fitness tracker. When the company first announced Whoop 5.0 this week, it said members who wanted the new device could either extend their subscriptions by 12 months or pay a one-time upgrade fee of $49 ($79 for the model with EKG
With long waiting lists and rising costs in overburdened healthcare systems, many people are turning to AI-powered chatbots like ChatGPT for medical self-diagnosis. About one in six American adults already use chatbots for health advice at least monthly, according to one recent survey. But placing too much trust in chatbots’ outputs can be risky, in
Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ReactWise is using AI to speed up chemical manufacturing — a key step in bringing new drugs to market. Once a promising drug has been identified in the lab, pharma firms need to be able to produce much larger amounts of
Last week, at the Abundance Summit in Los Angeles, billionaire entrepreneur Travis Kalanick gave attendees a rare glimpse into his vision for the future of his newest company, CloudKitchens. While today the eight-year-old L.A.-based outfit is known for a growing real estate portfolio that it uses to it host – and set up – restaurants
In the same way that genome sequencing determines the genetic makeup of an organism, Bryan Johnson — the investor and founder behind the Don’t Die movement — wants to start “foodome” sequencing. “We’re going to sequence the U.S. ‘foodome,’ which means test 20% of foods that constitute 80% of the American diet based on stuff
VC funding into AI tools for healthcare was projected to hit $11 billion last year — a headline figure that speaks to the widespread conviction that artificial intelligence will prove transformative in a critical sector. Many startups applying AI in healthcare are seeking to drive efficiencies by automating some of the administration that orbits and
Hinge Health, a 10-year-old company that offers a digital solution to treat chronic musculoskeletal (MSK) conditions, filed to go public. Although Hinge has not yet announced how many shares, nor priced them, the IPO specialists at Renaissance Capital estimate the company hopes to raise up to $500 million in its offering. Hinge’s revenue in 2024
